Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Gimeno Orna JA, Ortez Toro JJ, Peteiro Miranda CM
North America Glucagon-like Peptide-1 Agonists Market Size and Share North America Glucagon-like Peptide-1 Agonists Market Analysis by Mordor Intelligence The North America glucagon-like peptide-1 agonists market size is projected to be USD 28.66 billion in 2025, USD 32.43 billion in 2026, and reach USD 60.12 billion by 2031, growing at a CAGR of 13.14% from 2026 to 2031
72 SandersR
K., & Kang, J
Increased insulin secretion (glucose-dependent) Elevated GLP-1 and GIP enhance insulin release from pancreatic beta cells, but only in the presence of elevated blood glucose
US$ 26.94
US$ 25.38
US$ 25.84
US$ 20.80
US$ 27.29
US$ 27.82
US$ 20.47
US$ 25.49
